|
PLDN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.88098491916389E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.66133814775094E-16 |
| Normal-vs-Stage2 |
4.014200E-04 |
| Normal-vs-Stage3 |
1.001340E-04 |
| Normal-vs-Stage4 |
7.969000E-04 |
| Stage1-vs-Stage2 |
8.318400E-01 |
| Stage1-vs-Stage3 |
7.720500E-03 |
| Stage1-vs-Stage4 |
9.124900E-03 |
| Stage2-vs-Stage3 |
2.202400E-01 |
| Stage2-vs-Stage4 |
1.863560E-01 |
| Stage3-vs-Stage4 |
8.517200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67388325422735E-12 |
| Normal-vs-AfricanAmerican |
7.902600E-03 |
| Normal-vs-Asian |
8.714300E-02 |
| Caucasian-vs-AfricanAmerican |
6.996300E-02 |
| Caucasian-vs-Asian |
9.068400E-01 |
| AfricanAmerican-vs-Asian |
5.174800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85089721327358E-11 |
| Normal-vs-Female |
2.24450458219394E-11 |
| Male-vs-Female |
3.686800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.516500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.80377976181035E-12 |
| Normal-vs-Age(61-80Yrs) |
6.66260380199901E-11 |
| Normal-vs-Age(81-100Yrs) |
1.893540E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.474200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.680000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.300000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.786000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.147800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.580600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.763890E-03 |
| Normal-vs-Grade 2 |
1.62980740014973E-12 |
| Normal-vs-Grade 3 |
5.9250999662197E-09 |
| Normal-vs-Grade 4 |
3.721800E-02 |
| Grade 1-vs-Grade 2 |
4.242400E-01 |
| Grade 1-vs-Grade 3 |
4.565700E-02 |
| Grade 1-vs-Grade 4 |
5.198400E-03 |
| Grade 2-vs-Grade 3 |
6.822100E-03 |
| Grade 2-vs-Grade 4 |
2.154100E-04 |
| Grade 3-vs-Grade 4 |
3.046100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
7.678000000233E-07 |
| ccA subtype-vs-ccB subtype |
1.391680E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.61690669134396E-12 |
| Normal-vs-N1 |
2.560600E-01 |
| N0-vs-N1 |
3.160200E-01 |
|
|
